These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 6696750

  • 1. The effect of interferon on cells deficient in nucleoside transport or lacking thymidine kinase activity.
    Gewert DR, Cohen A, Williams BR.
    Biochem Biophys Res Commun; 1984 Jan 13; 118(1):124-30. PubMed ID: 6696750
    [Abstract] [Full Text] [Related]

  • 2. Induction of an anti-viral response and 2',5'-oligo A synthetase by interferon in several thymidine kinase-deficient cell lines.
    Lewis JA, Esteban M.
    Virology; 1984 Mar 13; 133(2):464-9. PubMed ID: 6324463
    [Abstract] [Full Text] [Related]

  • 3. Lack of correlation between thymidine kinase activity and the antiviral or antiproliferative response to interferon.
    Divizia M, Baglioni C.
    Virology; 1984 Feb 13; 133(1):216-9. PubMed ID: 6322432
    [Abstract] [Full Text] [Related]

  • 4. Characterization of mouse lymphoma cells with altered nucleoside transport.
    Cohen A, Leung C, Thompson E.
    J Cell Physiol; 1985 Jun 13; 123(3):431-4. PubMed ID: 3988815
    [Abstract] [Full Text] [Related]

  • 5. Thymidine incorporation in nucleoside transport-deficient lymphoma cells.
    Aronow B, Ullman B.
    J Biol Chem; 1985 Dec 25; 260(30):16274-8. PubMed ID: 3877729
    [Abstract] [Full Text] [Related]

  • 6. Nucleoside transport-deficient mutants of PK-15 pig kidney cell line.
    Aran JM, Plagemann PG.
    Biochim Biophys Acta; 1992 Sep 21; 1110(1):51-8. PubMed ID: 1390836
    [Abstract] [Full Text] [Related]

  • 7. Absence of binding sites for the transport inhibitor nitrobenzylthioinosine on nucleoside transport-deficient mouse lymphoma cells.
    Cass CE, Kolassa N, Uehara Y, Dahlig-Harley E, Harley ER, Paterson AR.
    Biochim Biophys Acta; 1981 Dec 21; 649(3):769-77. PubMed ID: 7317429
    [Abstract] [Full Text] [Related]

  • 8. Induction of anti-viral activity and specific enzymes in cell-lines derived from interferon-resistant, thymidine kinase deficient mouse L-929 cells.
    Lewis JA.
    Prog Clin Biol Res; 1985 Dec 21; 202():325-32. PubMed ID: 2421311
    [No Abstract] [Full Text] [Related]

  • 9. Residual nitrobenzylthioinosine-resistant nucleoside transport in a transport mutant (AE1) of S49 murine T-lymphoma cells.
    Plagemann PG, Woffendin C.
    Mol Cell Biol; 1987 Jan 21; 7(1):160-6. PubMed ID: 3494190
    [Abstract] [Full Text] [Related]

  • 10. AMP deaminase and thymidine kinase deficiencies in a mutant mouse S49 cell clone.
    Hanson S, Ullman B.
    Adv Exp Med Biol; 1989 Jan 21; 253B():79-86. PubMed ID: 2610148
    [Abstract] [Full Text] [Related]

  • 11. Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagents.
    Belt JA, Noel LD.
    Biochem J; 1985 Dec 15; 232(3):681-8. PubMed ID: 3004414
    [Abstract] [Full Text] [Related]

  • 12. Thymidine kinase genes and the induction of anti-viral responses by interferon.
    Mengheri E, Esteban M, Lewis JA.
    FEBS Lett; 1983 Jul 04; 157(2):301-5. PubMed ID: 6190677
    [Abstract] [Full Text] [Related]

  • 13. Incomplete nucleoside transport deficiency with increased hypoxanthine transport capability in mutant T-lymphoblastoid cells.
    Aronow B, Hollingsworth P, Patrick J, Ullman B.
    Mol Cell Biol; 1986 Apr 04; 6(4):1296-303. PubMed ID: 3491289
    [Abstract] [Full Text] [Related]

  • 14. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
    Bourgeade MF, Besançon F.
    Cancer Res; 1984 Nov 04; 44(11):5355-60. PubMed ID: 6435868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of a mutant mouse lymphoma cell with deficient transport of purine and pyrimidine nucleosides.
    Cohen A, Ullman B, Martin DW.
    J Biol Chem; 1979 Jan 10; 254(1):112-6. PubMed ID: 758311
    [Abstract] [Full Text] [Related]

  • 17. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M, Belkowski LS, Bloom BR.
    J Cell Biol; 1989 Sep 10; 109(3):1331-40. PubMed ID: 2549078
    [Abstract] [Full Text] [Related]

  • 18. Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells.
    Warner SJ, Friedman GB, Libby P.
    J Clin Invest; 1989 Apr 10; 83(4):1174-82. PubMed ID: 2495301
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma.
    Hochman J, Mador N, Gloger I, Falk H, Panet A.
    Exp Cell Res; 1988 Jul 10; 177(1):37-46. PubMed ID: 2455652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.